一项为期六年的纵向研究发现,低LDL胆固醇与2型糖尿病风险之间存在与他类药物无关的关联
Maria Lembo1, Valentina Trimarco2, Daniela Pacella3
1Department of Advanced Biomedical Sciences, "Federico II" University, Naples, Italy.
Cardiovascular diabetology
|November 11, 2025
概括
降低低密度脂蛋白胆固醇 (LDL-C) 与2型糖尿病 (T2D) 的更高风险有关. 这种关联独立于他类药物的使用,表明LDL-C可能表明T2D易感性.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 立方体治疗与2型糖尿病 (T2D) 的风险增加有关.
- 低密度脂蛋白胆固醇 (LDL-C) 和发生的T2D之间的关系需要进一步调查,特别是关于他类药物治疗的作用.
研究的目的:
- 研究血LDL-C度与T2D发病率之间的关联.
- 为了评估他类药物治疗是否改变LDL-C和T2D风险之间的关系,在一个基于人口的大队伍中进行评估.
主要方法:
- 在基线没有T2D和心血管疾病的个体的长度随访.
- 根据LDL-C水平和他类药物的使用,应用Cox比例危险模型来评估基于LDL-C水平和他类药物的新发病T2D风险.
主要成果:
- 在LDL-C血水平和发生的T2D之间发现了显著的反向关联 (p < 0.001).
- 最低LDL-C水平 (<84 mg/dL) 的个体患T2D的风险最高.
- 只有在非常高的LDL-C组 (≥131 mg/dL; p = 0.018) 中,他类药物治疗显著增加了T2D风险,而在其他LDL-C组中没有显著的修改.
结论:
- 在一般人群中,LDL-C和发生的T2D之间存在强烈的反向关联.
- 在较低的LDL-C水平下观察到的T2D风险增加似乎独立于他类药物的使用.
- LDL-C可以作为T2D易感性的潜在生物标志物.
相关概念视频
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Longitudinal Studies
456
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
456
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863


